PRESS RELEASE published on 05/23/2024 at 08:30, 3 months 26 days ago M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics M1 Kliniken AG reports strong profit growth in 2023, aiming for global market leadership in medical aesthetics. Annual report highlights sales increase and ambitious forecasts M1 Kliniken AG Annual Report Forecast Profit Growth Medical Aesthetics
BRIEF published on 05/07/2024 at 16:33, 4 months 11 days ago M1 Kliniken AG Announces Dividend and Positive Forecast for 2024 Earnings Report M1 Kliniken AG Dividend Financial Forecast 2024 Growth
BRIEF published on 05/07/2024 at 16:33, 4 months 11 days ago M1 Kliniken AG annonce un dividende et des prévisions positives pour 2024 Dividende Croissance 2024 Prévisions Financières Rapport Sur Les Revenus M1 Kliniken SA
PRESS RELEASE published on 05/07/2024 at 16:28, 4 months 11 days ago EQS-Adhoc: M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share M1 Kliniken AG's Supervisory Board approves 2023 financial statements with EUR 0.50 per share dividend proposal. Anticipates sales and earnings growth in 2024 Financial Statements M1 Kliniken AG Dividend Proposal Earnings Growth 2024 Forecast
BRIEF published on 04/30/2024 at 15:42, 4 months 18 days ago M1 Kliniken AG reçoit une évaluation positive des résultats préliminaires pour 2023 de la première recherche sur les actions de Berlin Recommandation De Stock Première Recherche Sur Les Actions À Berlin M1 Kliniken SA Performance Du Segment Beauté Marges EBIT
BRIEF published on 04/30/2024 at 15:42, 4 months 18 days ago M1 Kliniken AG Receives Positive Review on Preliminary 2023 Results from First Berlin Equity Research First Berlin Equity Research M1 Kliniken AG Stock Recommendation Beauty Segment Performance EBIT Margins
PRESS RELEASE published on 04/30/2024 at 15:37, 4 months 18 days ago Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research GmbH releases a research update on M1 Kliniken AG, reiterating a BUY rating and EUR 18.00 price target, based on strong 2023 Beauty segment results and continued expansion. Contact details provided M1 Kliniken AG BUY Rating Research Update First Berlin Equity Research GmbH EUR 18.00 Price Target
BRIEF published on 04/26/2024 at 11:11, 4 months 22 days ago M1 Kliniken AG annonce un programme de rachat d'actions Stratégie D'entreprise Rachat D'actions Finance Réglementation Sur Les Abus De Marché M1 Kliniken SA
BRIEF published on 04/26/2024 at 11:11, 4 months 22 days ago M1 Kliniken AG Announces Share Buyback Program Market Abuse Regulation M1 Kliniken AG Finance Stock Buyback Corporate Strategy
PRESS RELEASE published on 04/26/2024 at 11:06, 4 months 22 days ago EQS-Adhoc: M1 Kliniken AG decides to start share buyback M1 Kliniken AG initiates a share buyback program to repurchase up to 1,000,000 shares with a maximum total volume of EUR 12,600,000.00. The program aims to utilize repurchased shares for specified purposes Share Buyback M1 Kliniken AG Repurchase Share Law Aesthetic Medical
Published on 09/18/2024 at 23:10, 3 hours 47 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 3 hours 57 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 42 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 5 hours 57 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 27 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 45 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 25 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 43 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 35 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 11 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 11 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 17 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.